Suppr超能文献

[N-乙酰转移酶1基因多态性与散发性结直肠腺癌遗传易感性的关系研究]

[The research the relationship between N-acetyltransferase 1 gene polymorphisms and genetic susceptibility to sporadic colorectal adenocarcinoma].

作者信息

Zhang Youcai, Shi Zhaohong, Deng Changsheng, Zhu Youqing, Zhou Yan

机构信息

Department of Gasteroenterology, Zhongnan Hospital, Wuhan University, Wuhan Hospital, Wuhan, China.

出版信息

Zhonghua Nei Ke Za Zhi. 2002 Nov;41(11):746-9.

Abstract

OBJECTIVE

In this study, we analyzed the association genetic polymorphisms of N-acetyltransferase 1 (NAT1) with genetic susceptibility to sporadic colorectal adenocarcinoma (SCRAC).

METHODS

All subjects are unrelated Han people in Hubei province of China. Using multiple PCR and PCR-RFLP, we studied the genotypes and genetic polymorphisms of the NAT1 gene of 101 healthy controls and 104 SCRAC patients.

RESULTS

(1) The frequency of NAT1 * 10 was significantly higher among the SCRAC when compared with the controls (P < 0.05, OR = 1.91, 95% CI = 1.1 - 3.4), and among the elder SCRAC when compared to the controls (P < 0.01, OR = 2.91, 95% CI = 1.48 - 5.90), (2) The frequency of NAT1 * 10 relative to SCRAC tumor location as follow: proximal SCRAC (44.4%), distal SCRAC (41.6%), all the difference were not statistically significant relative to the controls; The frequency of NAT1 * 10 genotype was significantly higher in stage II cases (P < 0.05, OR = 2.48, 95% CI = 1.18 - 5.20) and stage III and IV cases (P < 0.05, OR = 3.04, 95% CI = 1.28 - 7.20) when compared with the controls.

CONCLUSIONS

NAT1 * 10 has increased risk of SCRAC and significantly related to the later stage tumors, is not significantly related to the tumor location, whether the elder individuals with NAT1 * 10 have increased risk of SCRAC needs further study.

摘要

目的

本研究分析了N - 乙酰基转移酶1(NAT1)基因多态性与散发性结直肠癌(SCRAC)遗传易感性的关系。

方法

所有受试者均为中国湖北省无血缘关系的汉族人。采用多重PCR和PCR - RFLP技术,研究了101例健康对照者和104例SCRAC患者NAT1基因的基因型和基因多态性。

结果

(1)与对照组相比,SCRAC患者中NAT1 * 10的频率显著更高(P < 0.05,OR = 1.91,95% CI = [1.1, 3.4]),与对照组相比,老年SCRAC患者中该频率更高(P < 0.01,OR = 2.91,95% CI = [1.48, 5.90]);(2)NAT1 * 10相对于SCRAC肿瘤位置的频率如下:近端SCRAC(44.4%),远端SCRAC(41.6%),与对照组相比所有差异均无统计学意义;与对照组相比,II期病例(P < 0.05,OR = 2.48,95% CI = [1.18, 5.20])以及III期和IV期病例(P < 0.05,OR = 3.04,95% CI = [1.28, 7.20])中NAT1 * 10基因型的频率显著更高。

结论

NAT1 * 10增加了SCRAC的发病风险,且与晚期肿瘤显著相关,与肿瘤位置无显著相关性,携带NAT1 * 10的老年个体SCRAC发病风险是否增加有待进一步研究。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验